Skip to main content
  • Poster presentation
  • Open access
  • Published:

Multifocal fixed drug eruption due to ornidazole


Ornidazole, a synthetic nitroimidazole derivative, is widely used in clinical practice. Ornidazol has low rate of side effects, but sometimes may cause significant allergic reactions such as fixed drug eruption (FDE). We describe a case of multifocal FDE caused by ornidazole.

Case report

A 40-year old woman applied to the Immunology and Allergy clinic with pruritic erythematous lesions over the lateral sides of both arms and right hip within 30 minutes after the ingestion of ornizadole 500 mg tablet. She reported that five recurrent reactions emerged with the same drug on the same locations previously, and their severity was increased consecutively. She was prescribed ornidazole for trichomonal vaginitis and she never warned physicians about the previous drug reactions. In view of the personal history and physical examination a diagnosis of FDE due to ornidazole was diagnosed. After a month from the last reaction allergy tests including prick, intradermal and patch tests were performed with ornidazole and metranidazole. Skin tests with 1/100 W/vol and 1/10 W/vol concentrations and undiluted form of the two drugs were negative. The patch tests consisted of the same drug concentrations were applied to the lesion site on her left arm. Readings were done at 48 hour later and positive results were obtained with ornidazole but not with metranidazole. A placebo controlled oral challenge was performed with metranidazole and no reaction was observed. Following, she contunied to receive metranidazole without any problem.


The lesionel patch test is more diagnostic than other allergy tests at recürrent fixed drug reactions. The patch test may be performed with the same drug solutions as performed on skin prick and intradermal tests without adding petrolatum. Although metronidazole and ornidazole are chemically related drugs, and metranidazole is known more susceptible to cause FDE, metranidazole may be an alternative drug to ornidazole like our case.

Author information

Authors and Affiliations


Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Demirel, F., Baysan, A., Yesillik, S. et al. Multifocal fixed drug eruption due to ornidazole. Clin Transl Allergy 4 (Suppl 3), P99 (2014).

Download citation

  • Published:

  • DOI: